174626-26-7

Basic information

• Product Name: Carbamic acid, [4-[(methylsulfonyl)oxy]butyl]-, phenylmethyl ester
• CAS NO: 174626-26-7
• Molecular Formula: C13H19NO5S
• Molecular Weight: 301.364
• Mol File: 174626-26-7.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [4-[(methylsulfonyl)oxy]butyl]-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [4-[(methylsulfonyl)oxy]butyl]-, phenylmethyl ester(174626-26-7)
• EPA Substance Registry System: Carbamic acid, [4-[(methylsulfonyl)oxy]butyl]-, phenylmethyl ester(174626-26-7)

Safety Data

• Hazardous Substances Data: 174626-26-7(Hazardous Substances Data)

Upstream product

• 17996-13-3 benzyl 4-hydroxybutylcarbamate 
• 124-63-0 methanesulfonyl chloride 
• 7143-01-3 Methanesulfonic anhydride 
• 501-53-1 benzyl chloroformate 

Downstream Products

• 123348-79-8 N-(benzyloxycarbonyl)-4-(dimethylamino)butylamine 
• 343248-70-4 (2S,13S)-2,6-cyclo-13,17-cyclo-21-(benzyloxycarbonylamino)-6,11,17-triaza-12-oxoheptadecanoic acid methyl ester 
• 343248-67-9 (2S)-N-(N'-(benzyloxycarbonyl)-4'-aminobutyl)-proline 
• 62146-62-7 (4-aminobutyl)carbamic acid benzyl ester 
• 123348-73-2 4-azido-N-benzyloxycarbonyl-1-butylamine 
• 343248-64-6 (2S)-N-(N'-(benzyloxycarbonyl)-4'-aminobutyl)-proline methyl ester 
• 251918-43-1 [4-(2,6-dioxo-3-propyl-1,2,3,6-tetrahydro-purin-7-yl)-butyl]-carbamic acid benzyl ester 

Relevant articles and documents

DEUTERATED FORMS OF AMINOSTEROLS AND METHODS OF USING THE SAME

Described are deuterated forms of aminosterols, or a pharmaceutically acceptable salt thereof, wherein one or more hydrogen atoms at one or more positions selected from C1, C2, C3, C4, C5, C6, C7, C8, C9, C11, C12, C14, C15, C16, C17, C18, C19, C20, C21,

Study on the Structure Activity Relationships of NPTX-594, a Spider Toxin Belonging to the Type-B Acylpolyamine Structure

In order to elucidate the structure activity relationships of the spider toxin termed NPTX-594, eleven toxin analogs were designed and synthesized, and their paralytic activities against cricket were tested. As a result of the present study, it was clarif

Condensed-purines syntheses of tetrahydro-1,4-diazepino[1,2,3-gh]purin- 2-one and hexahydro-1,4-diazocino[1,2,3-gh]purin-2-one

1,4-Pyrimido- (2a), 1,4-diazepino- (2b), and 1,4-diazocino[1,2,3- gh]purine (2c) were designed as selective cAMP-phosphodiesterase 4 (PDE 4) inhibitors. The desired condensed-purines (2b,c) were synthesized by reaction of 7-aminoalkyl-3-propylpurine-2,4-d